Investors
Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue.
Quarterly Results
We have released our results for the first quarter of 2023 on the 26th April 2023
First Quarter Results 2023 Webcast
We released our Q1 trading results for the quarter which ended 1 April 2023.
There was a conference call for financial analysts on the 26th April 2023.
A recording of the webcast has been made available on the site.
Investor Resources
Events
Annual General Meeting 2023
26 April 2023 Watford, UK
Event details
The Annual General Meeting (AGM) was held at 12:00pm on Wednesday, 26 April 2023 at Smith+Nephew Academy London, Building 5, Croxley Park, Hatters Lane, Watford, WD18 8YE.
Sustainability
As a portfolio medical technology company, Smith+Nephew’s purpose is to restore and promote health and wellbeing.
We believe that this applies not just to the benefits our products deliver to patients, but also to the wider health of the planet and society.